Fig. 4From: Development and clinical application of an integrative genomic approach to personalized cancer therapyActionability across multiple cancer types in this study. A summary of the distribution of recommendations across cancer types, where tier 1 and tier 2 drugs (see “Methods” for definitions) is displayed. "CRC" is colorectal cancerBack to article page